MNKD Q2 2019 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$841M

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$15M+285.4% YoY

Gross Profit

$9M56.9% margin

Operating Income

-$11M-73.0% margin

Net Income

-$12M-82.6% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

-14.0%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$21M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$82M

Total Liabilities

$278M

Stockholders' Equity

-$196M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$4M	+285.4%
Gross Profit	$9M	-$1M	+810.1%
Operating Income	-$11M	-$21M	+46.7%
Net Income	-$12M	-$23M	+45.4%

Revenue Segments

Product

$6M100%